Exchange: OTC·Updated 03:49 PM EDT
XTLB logo

XTLB XTL Biopharmaceuticals Ltd.

$2.13
$0.17
(7.39%)
Today
Mkt Cap$9.04M
Vol7,143.00

About XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
46

Neutral Sentiment

How do you feel about XTLB?

Advertisement|Remove ads.